AARD Insider Trading Activity and SEC Form 4 Filings
AARD insider trading summary
Over the past 12 months, insiders at Aardvark Therapeutics, Inc. (AARD) reported 2 open-market purchases worth $145K by 2 insiders and 2 sales worth $395K by 1 insider on SEC Form 4. Net insider selling was $250K.
Latest AARD insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 11, 2026 | Nelson Sun | See Remarks | Sell | $321K (62,000 @ $5.18) |
| Sep 10, 2026 | Nelson Sun | See Remarks | Sell | $74K (14,754 @ $5.00) |
| Dec 11, 2025 | Nelson Sun | Chief Financial Officer | Buy | $43K (3,000 @ $14.40) |
| Dec 11, 2025 | Tien-Li Lee | Chief Executive Officer | Buy | $101K (7,000 @ $14.48) |
| Sep 15, 2025 | Tien-Li Lee | Chief Executive Officer | Buy | $62K (6,500 @ $9.51) |
| Sep 15, 2025 | Tien-Li Lee | Chief Executive Officer | Buy | $35K (3,500 @ $9.94) |
| Sep 12, 2025 | Tien-Li Lee | Chief Executive Officer | Buy | $43K (5,000 @ $8.50) |
| Sep 11, 2025 | Tien-Li Lee | Chief Executive Officer | Buy | $47K (6,000 @ $7.82) |
| Sep 10, 2025 | Tien-Li Lee | Chief Executive Officer | Buy | $71K (9,000 @ $7.91) |
| Sep 9, 2025 | Nelson Sun | Chief Financial Officer | Buy | $48K (6,000 @ $8.07) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.